Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):51-9. doi: 10.1097/MEG.0b013e3283407158.
BACKGROUND/AIMS: This study was aimed at determining the postoperative mortality in patients with cirrhosis by Child-Turcotte-Pugh (CTP), Model for End-stage Liver Disease score (MELD), and Model for End-stage Liver Disease and Serum Sodium Concentration score (MELDNa) systems and to compare the predictability of the scoring systems.
Analysis was performed on clinical records of 490 patients with cirrhosis who underwent surgery under general anesthesia from January 2003 to December 2008.
(i) Ninety-day mortality in patients with CTP A, B, and C class were 2.1, 22.1 and 54.5%, respectively. (ii) Ninety-day mortality according to MELD score was as follows: 6-9, 3.5%; 10-14, 8.9%; 15-19, 14.3%; 20-24, 12.5%; and ≥25, 63.6%. (iii) Ninety-day mortality according to MELDNa score was as follows: 6-9, 1.9%; 10-14, 6.2%; 15-19, 13.2%; 20-24, 20.6%; and ≥25, 50%. (iv) Multivariable analysis showed that emergency surgery, American Society of Anesthesiologist class ≥IV, CTP score ≥7, MELD score ≥10, and MELDNa score ≥10 were independent risk factors for 90-day mortality. (v) The area under the receiver operating curve of CTP, MELD, and MELDNa in predicting 90-day mortality were 0.859, 0.761, 0.818, and nonparametric approach using the generalized U-statistic showed that the CTP score was equal to the MELDNa score (P=0.855) and the CTP and MELDNa scores were superior to the MELD score (P=0.027 and 0.047) in predicting postoperative 90-day mortality.
Mortality according to the CTP, MELD, and MELDNa scoring systems were determined and all scoring systems predicted postoperative mortality in patients with cirrhosis. The CTP score and MELDNa score were superior to the MELD score in predicting postoperative 90-day mortality.
背景/目的:本研究旨在通过 Child-Turcotte-Pugh(CTP)、终末期肝病模型(MELD)和终末期肝病和血清钠浓度模型(MELDNa)系统确定肝硬化患者的术后死亡率,并比较评分系统的预测能力。
对 2003 年 1 月至 2008 年 12 月期间在全身麻醉下接受手术的 490 例肝硬化患者的临床记录进行分析。
(i)CTP A、B 和 C 级患者的 90 天死亡率分别为 2.1%、22.1%和 54.5%。(ii)MELD 评分的 90 天死亡率如下:6-9,3.5%;10-14,8.9%;15-19,14.3%;20-24,12.5%;≥25,63.6%。(iii)MELDNa 评分的 90 天死亡率如下:6-9,1.9%;10-14,6.2%;15-19,13.2%;20-24,20.6%;≥25,50%。(iv)多变量分析显示,急诊手术、美国麻醉师协会分级≥IV、CTP 评分≥7、MELD 评分≥10 和 MELDNa 评分≥10 是 90 天死亡率的独立危险因素。(v)CTP、MELD 和 MELDNa 预测 90 天死亡率的受试者工作特征曲线下面积分别为 0.859、0.761、0.818,非参数广义 U 统计量显示 CTP 评分与 MELDNa 评分相等(P=0.855),且 CTP 和 MELDNa 评分优于 MELD 评分预测术后 90 天死亡率(P=0.027 和 0.047)。
根据 CTP、MELD 和 MELDNa 评分系统确定了死亡率,所有评分系统均预测了肝硬化患者的术后死亡率。CTP 评分和 MELDNa 评分优于 MELD 评分预测术后 90 天死亡率。